Who invested in Genome Medical?
Genome Medical's investors include Canaan, Perceptive Advisors, Casdin Capital, Illumina Ventures and LRVHealth, and 8 more on record.

United States · Series D startup
Funding summaryUpdated 26 Oct 2026
$98Mraised across 2 rounds since 2019, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $75M sold, first sale Sept 2024
Reported by FinSMEsSEC filing: $23M sold, first sale May 2019
From Genome Medical's own website: 4 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Genome Medical's investors include Canaan, Perceptive Advisors, Casdin Capital, Illumina Ventures and LRVHealth, and 8 more on record.
Genome Medical has raised $98M across 2 rounds since 2019.
Genome Medical's most recent round was a Series D of $75M in Sept 2024.
Its most recent round, $75M in Sept 2024, is also its largest on record.
Genome Medical's first round on record, in Jun 2019, was backed by Echo Health Ventures, Canaan and Perceptive Advisors and 8 others.
Genome Medical's latest named round is a Series D, in Sept 2024.
Genome Medical is based in the United States.
Echo Health Ventures led the Series B in 2019.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.